Headinvest, LLC Danaher Corp Transaction History

Headinvest, LLC

$497 Million
Q2 2024

A detailed history of Headinvest, LLC transactions in Danaher Corp stock. As of the latest transaction made, Headinvest, LLC holds 36,400 shares of DHR stock, worth $10.1 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares

36,400

Previous 36,596 0.54%

Holding current value

$10.1 Million

Previous $9.14 Million 0.48%

% of portfolio

1.83%

Previous 1.83%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $46,159 - $52,524	-196 Reduced 0.54%	36,400 $9.09 Million
Q1 2024 Aug 14, 2024	SELL	$224.58 - $256.19 $1.32 Million - $1.5 Million	-5,860 Reduced 13.8%	36,596 $9.14 Million
Q4 2023 Feb 12, 2024	SELL	$185.1 - $233.13 $29,801 - $37,533	-161 Reduced 0.38%	42,456 $9.82 Million
Q3 2023 Dec 11, 2023	BUY	$233.08 - $265.59 $22,142 - $25,231	95 Added 0.22%	42,617 $10.6 Million
Q2 2023 Aug 23, 2023	SELL	$224.99 - $256.14 $184,266 - $209,778	-819 Reduced 1.89%	42,522 $10.2 Million
Q1 2023 May 17, 2023	SELL	$239.75 - $277.0 $224,645 - $259,549	-937 Reduced 2.12%	43,341 $10.9 Million
Q4 2022 Feb 13, 2023	SELL	$241.42 - $282.29 $31,143 - $36,415	-129 Reduced 0.29%	44,278 $11.8 Million
Q3 2022 Dec 28, 2022	SELL	$247.06 - $1507.4 $43,235 - $263,795	-175 Reduced 0.39%	44,407 $11.5 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $30,587 - $38,656	-129 Reduced 0.29%	44,582 $11.3 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $125,547 - $154,090	-488 Reduced 1.08%	44,711 $13.1 Million
Q4 2021 Feb 11, 2022	SELL	$292.08 - $329.01 $629,432 - $709,016	-2,155 Reduced 4.55%	45,199 $14.9 Million
Q3 2021 Nov 16, 2021	SELL	$272.21 - $332.43 $198,985 - $243,006	-731 Reduced 1.52%	47,354 $14.4 Million
Q2 2021 Aug 30, 2021	SELL	$225.08 - $271.69 $116,816 - $141,007	-519 Reduced 1.07%	48,085 $12.9 Million
Q1 2021 May 13, 2021	SELL	$212.38 - $245.9 $344,905 - $399,341	-1,624 Reduced 3.23%	48,604 $10.9 Million
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $24,437 - $28,227	-115 Reduced 0.23%	50,113 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $24,437 - $28,227	115 Added 0.23%	50,228 $10.8 Million
Q3 2020 Nov 24, 2020	SELL	$177.16 - $215.33 $354,851 - $431,305	-2,003 Reduced 3.83%	50,228 $10.8 Million
Q2 2020 Aug 12, 2020	SELL	$128.7 - $176.83 $79,665 - $109,457	-619 Reduced 1.17%	52,231 $9.24 Million
Q1 2020 May 12, 2020	SELL	$121.39 - $169.05 $732,103 - $1.02 Million	-6,031 Reduced 10.24%	52,850 $7.32 Million
Q1 2020 May 11, 2020	BUY	$121.39 - $169.05 $506,439 - $705,276	4,172 Added 7.63%	58,881 $8.15 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $71,539 - $82,265	-536 Reduced 0.97%	54,709 $8.4 Million
Q3 2019 Nov 21, 2019	SELL	$135.4 - $146.47 $413,782 - $447,612	-3,056 Reduced 5.24%	55,245 $7.98 Million
Q2 2019 Aug 22, 2019	SELL	$124.88 - $143.73 $72,430 - $83,363	-580 Reduced 0.99%	58,301 $8.33 Million
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $5.98 Million - $8.1 Million	-61,261 Reduced 50.99%	58,881 $7.77 Million
Q4 2018 Feb 22, 2019	BUY	$94.85 - $109.54 $5.58 Million - $6.44 Million	58,781 Added 95.8%	120,142 $12.4 Million
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $11,284 - $12,523	-115 Reduced 0.19%	61,361 $6.67 Million
Q2 2018 Aug 09, 2018	SELL	$96.1 - $103.24 $56,506 - $60,705	-588 Reduced 0.95%	61,476 $6.07 Million
Q1 2018 Apr 09, 2018	SELL	$92.16 - $103.8 $75,110 - $84,597	-815 Reduced 1.3%	62,064 $6.08 Million
Q4 2017 Jan 30, 2018	SELL	$85.26 - $94.62 $120,216 - $133,414	-1,410 Reduced 2.19%	62,879 $5.84 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $5.1 Million - $5.69 Million	64,289	64,289 $5.93 Million

Others Institutions Holding DHR

# of Institutions

2,390

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $202B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.

Account